Jupiter to keep £500m of flagship fund after manager’s exit April 28, 2024 FTSE 250 asset manager Jupiter is set to keep nearly £500m of the funds run by the departing fund manager Ben Whitmore.
Fed set to hold rates this week – but markets will look for clues on cuts April 28, 2024 The Fed is almost certain to leave rates on hold when it announces its decision on Wednesday, but markets will be paying close attention to the central bank's forward guidance.
Moonpig nosedives after private equity firm sells 25m shares April 26, 2024 Thursday proved to be the worst day of trading in three years for personalised card company Moonpig, after a private equity firm sold 25 million of shares in the firm.
FTSE 100 closes at new record after breaching all-time high April 23, 2024 "This positive showing is exactly what’s needed to help repair the reputation of the UK stock market," Russ Mould, investment director at AJ Bell said.
FTSE 100 closes at new record but misses out on all-time high April 22, 2024 The FTSE 100 set a new record closing price at the beginning of the week, although it fell narrowly short of its all-time intra-day high set last February.
Equity markets shrug off geopolitical concerns after Iranian strikes April 15, 2024 Equity and commodity markets largely shrugged off geopolitical concerns following Iran's unprecedented drone strikes on Israel over the weekend.
Inchcape to sell its UK retail operations for £346m April 15, 2024 Inchcape's UK retail operation employs 3,600 people and sells vehicles from 80 sites.
City chiefs lament London Stock Exchange ‘doom loop’ after bruising exits April 13, 2024 Two top City figures have taken aim at the “doom loop” and negative media narrative gripping the London Stock Exchange after a bruising week of headlines for the beleaguered bourse.
FTSE 100: Investors should increase their exposure says Barclays April 10, 2024 Equity markets have been on a strong run over the past year or so, with tech firms in particular driving a large part of the gains.
‘Lack of appetite’ in London drives another high-tech firm to Nasdaq April 10, 2024 In a statement to markets this morning, London-HQd e-therapeutics said it has "an intention to cancel its admission to AIM and subsequently explore the option of listing on NASDAQ in due course."